Resolute Holdings Management
RHLD
115.00
-0.64
-0.55%
Resolute Holdings Management
US · RHLD
#3315 by market cap
115.00
-0.64
-0.55%
Live - 5344 symbols - heartbeat 518s ago
· 2026-10-07 20:02
After-hours
115.00
0.00%
Overnight
115.92
+0.80%
- Market cap
- 899.25M
- P/E (TTM)i
- 20.35
- P/Bi
- -28.55
- EPSi
- -0.69
- Div yieldi
- 0.00%
- 52W posi
- 27%
Reader sentiment
Are you bullish or bearish on RHLD?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.65, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 5 years
Latest year +9.86% YoY
Margins
- Gross margin
- 56.32%
- Operating margin
- 31.00%
- Net margin
- -1.28%
Key ratios & quality
- Enterprise valuei
- 880.79M
- Altman Z-Scorei
- 5.65
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 267.95M | 378.48M | -- | 420.57M | 462.06M |
| Gross profit | 144.85M | 219.64M | -- | 219.23M | 260.21M |
| Selling & admin expenses | 63.42M | 95.96M | -- | 92.68M | 116.95M |
| Research & development | -- | -- | -- | -- | -- |
| Operating profit | 81.43M | 123.68M | -- | 126.55M | 143.26M |
| Pretax profit | 82.56M | 102.69M | -- | 110.12M | 134.90M |
| Tax | -857.00K | -- | -- | -24.00K | 885.00K |
| Net profit | 83.41M | 102.69M | -- | 110.15M | 134.02M |
| Basic EPS | 0 | 12 | -- | 0 | -1 |
| Diluted EPS | 0.37 | 12.10 | -- | -0.28 | -0.69 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 103.90M | 119.60M | 120.87M | 117.71M | 407.80M | 473.20M |
| Gross profit | 54.50M | 68.80M | 71.33M | 65.54M | 155.60M | 165.00M |
| Selling & admin expenses | 28.90M | 28.20M | 29.87M | 29.99M | 162.60M | 129.80M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 25.60M | 40.60M | 41.46M | 35.55M | -7.00M | 35.20M |
| Pretax profit | 23.20M | 38.60M | 39.47M | 33.66M | -142.40M | 97.50M |
| Tax | 600.00K | 300.00K | 63.00K | -45.00K | -49.80M | 42.80M |
| Net profit | 22.60M | 38.30M | 39.41M | 33.70M | -92.60M | 54.70M |
| Basic EPS | 0 | 0 | 0 | 0 | 7 | -2 |
| Diluted EPS | -0.39 | -0.07 | -0.03 | -0.20 | 7.19 | -1.53 |
Balance sheet
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total current assets | -- | -- | -- | 166.59M | 297.65M |
| Cash & ST investments | -- | -- | -- | 71.59M | 205.50M |
| Inventory | -- | -- | -- | 44.83M | 44.21M |
| Total assets | -- | -- | -- | 201.79M | 333.42M |
| Total current liabilities | -- | -- | -- | 50.15M | 77.53M |
| Short-term debt | -- | -- | -- | 13.36M | 17.24M |
| Long-term debt | -- | -- | -- | 184.39M | 169.79M |
| Total liabilities | -- | -- | -- | 238,422,000.00 | 255,649,000.00 |
| Total equity | -- | -- | -- | -36.63M | 77.77M |
| Retained earnings | -- | -- | -- | -2.33M | -12.36M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 176.18M | 217.07M | 259.19M | 297.65M | 937.50M | 818.10M |
| Cash & ST investments | 71.02M | 99.86M | 147.97M | 205.50M | 113.10M | 117.00M |
| Inventory | 47.50M | 44.24M | 43.75M | 44.21M | 411.10M | 322.90M |
| Total assets | 214.29M | 253.29M | 293.17M | 333.42M | 6.22B | 6.13B |
| Total current liabilities | 48.82M | 63.88M | 70.53M | 77.53M | 588.60M | 605.40M |
| Short-term debt | 14.61M | 15.91M | 17.21M | 17.24M | 9.00M | 35.50M |
| Long-term debt | 180.71M | 177.07M | 173.43M | 169.79M | 2.18B | 2.15B |
| Total liabilities | 238,294,000.00 | 249,150,000.00 | 251,592,000.00 | 255,649,000.00 | 3,133,600,000.00 | 3,073,900,000.00 |
| Total equity | -24.01M | 4.14M | 41.58M | 77.77M | 3.08B | 3.05B |
| Retained earnings | -5.70M | -6.31M | -6.54M | -12.36M | 53.20M | 40.80M |
Cash flow
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating cash flow | 77.78M | 95.61M | 117.02M | 152.10M | 196.09M |
| Depreciation & amortization | 10.43M | 8.58M | 8.39M | 9.17M | 9.38M |
| Free cash flow | 73.03M | 86.56M | 106.07M | 143.66M | 187.72M |
| Dividends paid | -22.33M | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | 0 | -4.10M |
| Ending cash balance | 21.94M | 8.26M | 38.19M | 71.59M | 161.37M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 18.40M | 49.00M | 59.48M | 69.21M | -116.80M | 93.60M |
| Depreciation & amortization | 2.30M | 2.30M | 2.30M | 2.48M | 59.30M | 64.30M |
| Free cash flow | 17.20M | 47.40M | 58.09M | 65.03M | -128.50M | 78.20M |
| Dividends paid | -- | -- | -3.03M | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | -- | -- | -38.00M | -49.50M |
| Ending cash balance | 71.00M | 99.90M | 98.25M | 161.37M | 120.10M | 117.00M |
Returns & efficiency
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| ROE %i | -- | -- | -- | -- | -- |
| ROA %i | -- | 58.62 | -1.64 | -9.47 | -3.31 |
| ROIC %i | -- | -- | -- | -- | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- |
| EBIT margin %i | 35.26 | 33.09 | 26.55 | 30.98 | 32.05 |
| FCF / sales %i | 27.26 | 22.87 | 27.15 | 34.16 | 40.63 |
| Current ratioi | -- | -- | -- | 0.00 | 3.84 |
| Quick ratioi | -- | -- | -- | 0.00 | 3.22 |
| Debt / assetsi | -- | -- | -- | -- | 58.59 |
| LT debt / equityi | -- | -- | -- | -- | 2,730.68 |
| Interest coveragei | 7.92 | 5.56 | 4.29 | 6.46 | 11.22 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -64.27 | -65.66 | -60.40 | -- | 301.14 | -- |
| ROA %i | -2.66 | -2.49 | -2.23 | -3.31 | 1.83 | 1.48 |
| ROIC %i | 3.15 | 1.25 | -0.44 | -- | 6.59 | -- |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 29.48 | 30.49 | 31.51 | 32.05 | 1.19 | 8.82 |
| FCF / sales %i | 30.16 | 32.43 | 36.80 | 40.63 | 5.49 | 6.50 |
| Current ratioi | 3.61 | 3.40 | 3.67 | 3.84 | 1.59 | 1.35 |
| Quick ratioi | 2.56 | 2.65 | 3.01 | 3.22 | 0.73 | 0.69 |
| Debt / assetsi | 95.24 | 79.43 | 67.63 | 58.59 | 35.19 | 36.63 |
| LT debt / equityi | 2,136.37 | 1,927.73 | 1,671.72 | 2,730.68 | 7,189.11 | -- |
| Interest coveragei | 7.28 | 9.42 | 12.71 | 11.22 | 0.23 | 1.40 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Husky is the largest reported line at 71.77% of revenue, across 4 reported segments.
- The next-largest line, CompoSecure, is a distant second at 28.23% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Husky71.77%
CompoSecure28.23%
Resolute Holdings2.87%
Quote time 2026-10-07 20:02:17 · For reference only, not investment advice and not tailored to your situation.